How Is Kimberly-Clark's Stock Performance Compared to Other Consumer Defensive Stocks?

Barchart
Abrir em Barchart
How Is Kimberly-Clark's Stock Performance Compared to Other Consumer Defensive Stocks?

With a market cap of $34.2 billion, Kimberly-Clark Corporation (KMB) is a U.S.-based manufacturer and marketer of personal care and household products. The company operates through two main segments: North America and International Personal Care, offering products such as diapers, baby wipes, feminine and incontinence care items, and tissue products under brands like Huggies, Kleenex, Kotex, and Scott. 

Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and Kimberly-Clark fits this criterion perfectly. It sells its products to retailers, distributors, businesses, and e-commerce channels, serving both household consumers and professional facilities worldwide.

More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.

 

Shares of the Dallas, Texas-based company have pulled back 23.1% from its 52-week high of $130.83. The stock has fallen marginally over the past three months, in line with the broader State Street Consumer Staples Select Sector SPDR ETF’s (XLP) performance over the same period.

www.barchart.com

KMB stock is down marginally on a YTD basis, lagging behind XLP’s 7.8% rise. In the longer term, shares of the consumer products company have dipped 23.7% over the past 52 weeks, compared to XLP’s 3.7% return over the same time frame.

Yet, the stock has been trading above its 200-day moving average since late June. 

www.barchart.com

Kimberly-Clark reported Q2 2026 results on Aug. 4, with fiscal 2026 adjusted EPS attributable to Kimberly-Clark expected to decline at a low-single-digit rate on a constant-currency basis and organic sales growth is projected to be about 100 basis points below its weighted-average category growth of roughly 2%. The outlook was pressured by China’s diaper-market disruption, which reduced Q2 organic sales growth by about 50 basis points and is expected to have a further near-term impact on sales and profits, alongside business exits and higher brand and supply-chain investments. 

Although Q2 adjusted EPS from continuing operations rose 10.4% to $1.80 and adjusted operating profit increased 6.2% to $757 million, these gains were partly offset by a 210-basis-point headwind from business exits and the China disruption.

In comparison, rival The Procter & Gamble Company (PG) has outpaced KMB stock. Shares of Procter & Gamble have gained marginally on a YTD basis and decreased 9.3% over the past 52 weeks.

Despite Kimberly-Clark’s weak performance relative to its peers, analysts are moderately optimistic about its prospects. The stock has a consensus rating of “Moderate Buy” from the 16 analysts covering it, and the mean price target of $117.18 is a premium of 13.8% to current levels. 


On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

 

More news from Barchart

Dear SailPoint Stock Fans, Mark Your Calendars for September 9 Morgan Stanley Deems Apple's September 9 Event 'Most Consequential in a Decade': What AAPL Stock Investors Should Know Huawei and Xiaomi Take on Apple Before Its Foldable iPhone Launch. What This Means for AAPL Stock. Following Activist Investor Elliott’s Large Stake Purchase, Here’s What It Will Take for Deutsche Telekom to Stage a Recovery